Sponsors

RECENT NEWS

PathAI launches Precision Pathology Network

Artificial intelligence and digital pathology firm PathAI has unveiled the launch of the Precision Pathology Network (PPN), a first-of-its-kind network of digital anatomic pathology laboratories, which aims to platform expands access to latest AI products, unlock real-world data value, and fuel collaborative research with biopharma across a broad network.

AI improves pathologists' interpretation of tissue samples

Pathologists' examinations of tissue samples from skin cancer tumours improved when they were assisted by an AI tool. The assessments became more consistent and patients' prognoses were described more accurately, details a new study.

Novel nanobody effective against henipaviruses

Researchers have discovered a strategy to neutralise two highly lethal henipaviruses for which there is currently no approved vaccine or cure.

Lunit and Microsoft collaborate to advance AI-driven cancer diagnosis

Lunit, a provider of AI for cancer diagnostics and therapeutics, has announced a new collaboration with Microsoft to accelerate the delivery of AI-powered healthcare solutions.

Connected Care appointment for BD

Becton Dickinson (BD) has named Bilal Muhsin as Executive Vice President and President of BD's future Connected Care segment, as part of the company's previously announced plans to update its structure as it advances its New BD strategy.

Taskforce urges action on screening workforce

A major report launched from the Women’s Cancer Screening Taskforce has issued a clear call to Government and NHS leaders: prioritise investment in the workforce behind breast and cervical cancer screening to deliver earlier diagnoses and improve outcomes for women across the UK.

Bio-Rad expands Droplet Digital PCR offering

Bio-Rad Laboratories has announced the launch of four new Droplet Digital PCR (ddPCR) platforms. The newly introduced instruments include Bio-Rad’s QX Continuum ddPCR system (pictured) along with the QX700 series of ddPCR platforms acquired as part of the company’s recently completed acquisition of digital PCR developer Stilla Technologies.

Reaction to the NHS 10 Year Plan

Following the publication of the Government’s long-awaited 10 Year Plan for the future of the National Health Service, professional and industry bodies have been responding.

10 Year Plan’s ‘Innovator passports’ to boost MedTech

A new ‘innovator passport’ - to be introduced over the next two years - will allow new technology that has been robustly assessed by one NHS organisation to be easily rolled out to others.

Shift to local care headlines NHS 10 Year Plan

NHS patients will be treated and cared for closer to their home by new teams of health professionals, as Prime Minister Keir Starmer revealed the long-awaited 10 Year Plan. The government describes the change as a “brand-new era for the NHS” promising to deliver one of the most seismic shifts in care in the history of the health service.

Genetic link between weight-loss jabs and pancreatitis investigated

The pioneering Yellow Card Biobank, launched by the Medicines and Healthcare products Regulatory Agency (MHRA) and Genomics England, is investigating whether the risk of acute pancreatitis from GLP-1 injections for weight loss and type 2 diabetes may be influenced by a person’s genes.

Diatron launches new flagship clinical chemistry system

Diatron has launched its new clinical chemistry analyser, the P780. The system is designed to provide outstanding performance and maximum efficiency, without compromising affordability, to meet the growing demands of modern laboratories.

New research reveals enzyme's influence over cancer cells

Cell biologists have made a significant advance, uncovering the key role of an enzyme in determining the physical structure and behaviour of cancer cells, including how they spread.

IBMS welcomes Government Industrial Strategy

The Institute of Biomedical Science (IBMS) has welcomed the publication of the new Industrial Strategy and its focus on life sciences.

Updated Business Plan published by MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) has published its Business Plan for 2025–26, the final year covered by its 2023-2026 Corporate Plan.

PathAI DP platform receives FDA clearance for primary diagnosis

Digital pathology and AI firm PathAI has announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for AISight Dx - its digital pathology image management system - for use in primary diagnosis in clinical settings.

EVIDENT launches new CE-marked whole-slide scanner

Evident has announced the launch of the SLIDEVIEW DX VS200 universal whole-slide imaging scanner, a CE-marked device under the EU IVDR for use in clinical diagnostics in Europe.

MHRA to lead safe use of AI in global healthcare

The MHRA will help shape international rules for AI in healthcare – speeding up access to safe, effective technologies into the NHS and worldwide, after the UK became one of the first countries in the world to join a new global network of health regulators.

LabMed welcomes new President

Clinical scientist Ian Godber stepped into the role of President of the Association for Laboratory Medicine (LabMed), at LabMedUK25 in Manchester on 11 June 2025, officially succeeding Kath Hayden. The Association also unveiled a new five-year strategy at the event.

PathPresenter receives FDA clearance for digital pathology Clinical Viewer

PathPresenter, an image management system and workflow platform for digital pathology, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the PathPresenter Clinical Viewer for the purpose of primary diagnosis.

Latest Issues

Annual SHOT Symposium

Hilton Birmingham Metropole Hotel, B40 1P
11 July 2025

IHC technical issues masterclass

UK NEQAS CPT, The Haylofts, Newcastle
13 August, 2025